Home » Topics » BioWorld Science

BioWorld Science
RSS

PDE9 inhibition shows preclinical promise for the treatment of obesity and cardiometabolic syndrome

Oct. 19, 2021

Hygromycin A clears B. burgdorferi infection in mice

Oct. 19, 2021

Atsena discloses preclinical gene therapy program for X-linked retinoschisis

Oct. 19, 2021

CELSR2 regulates lipid homeostasis and it is a therapeutic target in NAFLD

Oct. 19, 2021

Orexia and Schrodinger collaborate to discover novel therapeutics targeting OX2 receptor

Oct. 19, 2021

CoImmune and MSK collaborate to adapt CAR-CIK technology to treat solid tumors

Oct. 19, 2021

Cannabidiol-carbamate hybrid shows therapeutic potential in models of AD

Oct. 19, 2021

Exo Therapeutics divulges new EED inhibitors

Oct. 19, 2021

Carna Biosciences identifies hSTING antagonists

Oct. 19, 2021

Janssen BioPharma presents new influenza endonuclease inhibitors

Oct. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...